TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Particle Therapy Program Would cost $600 million Over 10 Years for 16 Facilities, Clinical Trials December 2, 1977
TCL Archive Organ Systems Program Finally Loses a Couple, But Gets OK for Breast Cancer Risk Study RFA June 20, 1986
TCL Archive TCGA Researchers Discover Stomach Cancer Falls Into Four Distinct Molecular Subtypes August 29, 2014
TCL Archive In Brief: Christopher Walsh Named Dana-Farber President; Sachs Leaves NCI; Acoustic Neuroma Conference August 16, 1991